author-photo

F. Caligaris Cappio

12

Papers

191

Citations

Citation Trend

Filter By

Papers (7) Sort By

Journal Conference Others

Phase Ib study of NGR-hTNF, a selective vascular targeting agent, administered at low doses in combination with doxorubicin to patients with advanced solid tumours

2009 British Journal of Cancer
Show All
- Source
- Cite
- Save
Citations (75)
6617 Phase II study of NGR-hTNF, a selective vascular targeting agent (VTA), in previously treated patients (pts) with advanced hepatocellular carcinoma (HCC)

2009 Ejc Supplements
Show All
- Source
- Cite
- Save
Citations (2)
9011 NGR-hTNF, a vascular targeting agent (VTA), in previously treated patients with malignant pleural mesothelioma (MPM): a phase II study

2009 Ejc Supplements
Show All
- Source
- Cite
- Save
Citations (2)
A phase I study to define the optimal low dose of NGR-hTNF, a novel vascular targeting agent (VTA), in combination with cisplatin in patients (pts) with solid tumors

2008 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (3)
Cyclophosphamide/cyclosporin-A treatment of multicentric Castleman's disease with Kaposi's sarcoma

2000 Haematologica
Show All
- Source
- Cite
- Save
Citations (2)
ANEMIA OF CHRONIC DISORDERS IN SYSTEMIC AUTOIMMUNE DISEASES

1997 Haematologica
- Mt Bertero
- F. Caligaris Cappio
Show All
- Source
- Cite
- Save
Citations (84)
Analysis by Monoclonal Antibodies of Cell Surface Structures Marking Discrete Steps of Cell Differentiation

1985 Protides of the biological fluids
Show All
- Source
- Cite
- Save
Citations (2)